(Q37315386)

19 August 2017

1 reference

title

The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis (English)

1 reference

stem cell transplantation

19 August 2017

main subject

1 reference

N Cooper

1

1 reference

19 August 2017

K Rao

2

1 reference

19 August 2017

N Goulden

3

1 reference

19 August 2017

D Webb

4

1 reference

19 August 2017

P Amrolia

5

1 reference

19 August 2017

P Veys

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Bone Marrow Transplantation

19 August 2017

published in

1 reference

19 August 2017

volume

42 Suppl 2

1 reference

19 August 2017

page(s)

S47-50

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2008.283

19 August 2017

exact match

0 references

cites work

Familial hemophagocytic lymphohistiocytosis: diagnostic problems and differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Current therapy for Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: Experience of the French Langerhans Cell Study Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.283

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.283

1 reference

Dimensions Publication ID

19 August 2017

1009206567

0 references

1 reference